Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

New evidence on stemming low-value prescribing.

Sacarny A, Barnett ML, Agrawal S. NEJM Catalyst. April 10, 2019.

Save
Print
May 1, 2019
Sacarny A, Barnett ML, Agrawal S. NEJM Catalyst. April 10, 2019.
View more articles from the same authors.

Overprescribing contributes to polypharmacy, antibiotic resistance, and opioid misuse. This commentary discusses strategies to change prescriber behavior such as peer comparisons and opioid overdose letters to prescribers whose patients recently overdosed to drive improvement and reflection.

Save
Print
Cite
Citation

Sacarny A, Barnett ML, Agrawal S. NEJM Catalyst. April 10, 2019.

Related Resources From the Same Author(s)
Related Resources